ICU病人营养支持护理与临床应用

目的：通过营养管理、营养支持、保障危重病人的细胞和脏器功能。方法：采用经周围置入中心导管（PICC）输注营养液。结果：避免中心静脉置管并发症。对很多危重病人获得抢救机会得以康复。结论：临床营养支持的实施，提高了多种特殊肠道疾病的治愈率。     

调脂与抗氧化类抗动脉粥样硬化药物研究进展

目前临床常用的调脂类药物包括3-羟-3-甲基戊二酰辅酶A还原酶（HMG CoA还原酶）抑制剂、苯氧乙酸衍生物（贝特类）、烟酸类和胆汁酸结合树脂，各类药物各有其特点，以HMG CoA还原酶抑制剂使用最为广泛；抗氧化类主要有天然抗氧化剂如VitC、VitE和β-胡萝卜素和合成抗氧化剂如普罗布考（又名丙丁酚），而后者的应用得到了大量循证医学证据的支持。因此，选用调脂与抗氧化类抗动脉粥样硬化药物应依据循证医学的结果，遵循安全、有效、经济的原则。     

酞菁类聚合物功能材料研究进展

本文概述酞菁类聚合物作为功能材料的研究进展，详细讨论了酞菁类聚合物的分类、制备方法、性能研究以及应用领域。     

SARS病毒研究进展

严重急性呼吸综合征 (SevereAcuteRespiratorySyndrome ,SARS)是由SARS病毒引起的一种急性呼吸道传染病 ,主要通过近距离空气飞沫和密切接触传播。SARS病毒是冠状病毒的一个变种 ,以前从未在人类或其它动物中发现。基因组全长约为 3 0Kb ,主要编码五种与病毒侵入、复制有关的结构蛋白 (RNA聚合酶、S、M、E、N蛋白 ) ,这些蛋白质的结构和功能对于今后设计疫苗和抗病毒药物至关重要。到目前为止 ,致病机理还不十分清楚。SARS病毒感染的实验室检测方法主要有细胞培养、分子生物学检测和抗体检测     

The development of pediatric neurosurgery in Paris How to create something out of nothing: reflexions on the methodology

Up to 1960, children in need of neurosurgical treatment in France were treated either in neurosurgical departments where anesthetists, nurses and neurosurgeons had no specialized training in pediatrics or in departments of pediatric surgery in which the specific aspect of neurosurgery was ignored. Clearly a mutation was needed before any progress could be made: the development of pediatric neurosurgery services. This essay tells the story of the creation of the first pediatric neurosurgery service in France, of the difficulties encountered and of the strategies applied to overcome them. It also recalls the discussions about what size such a service should be and whether it should be located in a general hospital or in a pediatric hospital. During the second half of the twentieth century, progress in neurosurgery, and more specifically in pediatric neurosurgery, has been tremendous. The contribution of the pediatric neurosurgery service at Les Enfants Malades in Paris is briefly summarized.     

围术期肺动脉高压的麻醉处理及其研究进展

目的:进一步了解围术期肺动脉高压的相关知识,并探讨其麻醉处理方法及研究进展。方法:查阅文献,综合论点。结果和结论:围术期肺动脉高压的麻醉处理方法很多,主要应做到以下几点:①维持血流动力学稳定;②维持心肌氧的供需平衡;③加强呼吸管理;④合理应用血管活性药物。     

临床止血材料的应用现状及研究进展

随着科学技术的发展,临床上常常采用止血材料进行止血,目前市场已开发出由不同来源和不同止血机制组成的局部止血材料,因其不同特性而应用各异。该文通过查阅文献回顾近几年来临床常用的止血材料,就其种类、组成、止血机制和临床适应症做简要综述,并对未来止血材料进行展望。     

新喹诺酮类药物研究进展

目的观察新喹诺酮类药物的研究进展。方法通过检索、查阅国内外文献,分析、归纳了新喹诺酮类药物在作用机制、抗菌活性、药代动力学、不良反应、耐药性及未来的研究方向。结果新喹诺酮类药物较以往前三代,具有更强的抗菌谱、更强的抗菌活性、优良的药动学特征及较低的不良反应。结论新喹诺酮类药物以其良好的特性,现在以及将来都将在抗感染治疗发挥更好的作用。     

迟发性运动障碍的诊断和治疗进展

迟发性运动障碍（tardivedyskinesia，TD）又称为迟发性多动症，是1968年由Crane首先提出的一种疾病。该病多见于大剂量长期服用抗精神病药物之后的患者，临床主要特点为不自主、有节律的重复刻板式运动。本文对TD的临床诊断、表现特征以及治疗进行相关综述。     

Postępy w leczeniu chłoniaka Hodgkina u dzieci i młodzieży

Currently over 90% children and adolescents with Hodgkin's lymphoma (HL) can be cured. In the recent 25 years successive improvement of results of treatment was achieved through proper choice of treatment intensity according to precisely defined risk groups. The current strategy of diagnosis and treatment of HL is aimed at balancing between the highest possible cure rates and risk of late complications. On the basis of 40-year experience of Polish Pediatric Leukemia/Lymphoma Study Group and recent data from literature we review current and planned strategies of therapeutic management aimed for improving results of treatment in patients with poor prognosis and reducing rates of late complications in all patients with HL. Currently further reduction of radiotherapy use is considered through limiting its use in the patients with satisfactory results after initial chemotherapy evaluated with the use of positron emission tomography results. Further improvement of therapeutic strategy for HL calls associating individual oncological centers in large groups, which would cooperate in completing research projects.